Cancer Immunotherapy - 2-4 February 2017, Heidelberg, Germany

The 2017 EMBL-Cancer Core Europe Conference on Cancer Immunotherapy will cover highly relevant sub-disciplines of cancer immunology with a special focus on personalised immunotherapy. The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.
Source: EUROPA - Research and Innovation: Events - Category: Research Tags: Life sciences - 7DB37216-D9A7-5F19-1F4B02B58D353C4B Source Type: events